share_log
Reuters ·  Mar 26 10:45
European Commission (Ec) Approves Merck’s Capvaxive® (Pneumococcal 21-Valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 362

Recommended

Write a comment